Novel |
PRKDC |
protein kinase, DNA-activated, catalytic subunit |
- Cytosolic sensors of pathogen-associated DNA
- IRF3-mediated induction of type I IFN
- Nonhomologous End-Joining (NHEJ)
- E3 ubiquitin ligases ubiquitinate target proteins
|
|
|
Novel |
PTGDS |
prostaglandin D2 synthase |
- Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
- Transcriptional regulation of testis differentiation
|
|
|
Novel |
PTGES3 |
prostaglandin E synthase 3 |
- Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
- HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
- HSF1 activation
- Attenuation phase
- Aryl hydrocarbon receptor signalling
- ESR-mediated signaling
- Estrogen-dependent gene expression
- Potential therapeutics for SARS
|
- Acetaminophen
- Grn163l
- Copper
|
|
Novel |
PTP4A2 |
protein tyrosine phosphatase 4A2 |
|
|
|
Novel |
PTPRF |
protein tyrosine phosphatase receptor type F |
- Receptor-type tyrosine-protein phosphatases
- Insulin receptor recycling
- Synaptic adhesion-like molecules
|
|
|
Novel |
RAD51 |
RAD51 recombinase |
- HDR through Single Strand Annealing (SSA)
- HDR through Homologous Recombination (HRR)
- Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
- Resolution of D-loop Structures through Holliday Junction Intermediates
- Homologous DNA Pairing and Strand Exchange
- Presynaptic phase of homologous DNA pairing and strand exchange
- Transcriptional Regulation by E2F6
- Meiotic recombination
- Meiotic recombination
- Defective homologous recombination repair (HRR) due to BRCA1 loss of function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
- Impaired BRCA2 binding to RAD51
- Impaired BRCA2 binding to PALB2
|
- Phosphoaminophosphonic Acid-Adenylate Ester
- Amuvatinib
|
|
Novel |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
- Stimuli-sensing channels
- Rap1 signalling
- GP1b-IX-V activation signalling
- CD209 (DC-SIGN) signaling
- RAF activation
- MAP2K and MAPK activation
- Negative feedback regulation of MAPK pathway
- Negative regulation of MAPK pathway
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- SHOC2 M1731 mutant abolishes MRAS complex function
- Gain-of-function MRAS complexes activate RAF signaling
- IFNG signaling activates MAPKs
|
- Sorafenib
- LErafAON
- XL281
- iCo-007
- Cholecystokinin
- Regorafenib
- Dabrafenib
- Fostamatinib
|
|
Novel |
RHOBTB2 |
Rho related BTB domain containing 2 |
|
|
|
Novel |
RIPK1 |
receptor interacting serine/threonine kinase 1 |
- Caspase activation via Death Receptors in the presence of ligand
- TICAM1, RIP1-mediated IKK complex recruitment
- RIP-mediated NFkB activation via ZBP1
- TRIF-mediated programmed cell death
- TRP channels
- Regulation by c-FLIP
- RIPK1-mediated regulated necrosis
- CASP8 activity is inhibited
- TNFR1-induced proapoptotic signaling
- Regulation of TNFR1 signaling
- TNFR1-induced NF-kappa-B signaling pathway
- Regulation of necroptotic cell death
- Ub-specific processing proteases
- Ovarian tumor domain proteases
- Dimerization of procaspase-8
- TNF signaling
- TLR3-mediated TICAM1-dependent programmed cell death
- NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
- IKK complex recruitment mediated by RIP1
- Potential therapeutics for SARS
- Microbial modulation of RIPK1-mediated regulated necrosis
- SARS-CoV-1-mediated effects on programmed cell death
- Defective RIPK1-mediated regulated necrosis
|
|
|
Novel |
RIPPLY3 |
ripply transcriptional repressor 3 |
|
|
|
Novel |
RPAP3 |
RNA polymerase II associated protein 3 |
|
|
|
Novel |
RPS3 |
ribosomal protein S3 |
- L13a-mediated translational silencing of Ceruloplasmin expression
- Peptide chain elongation
- SRP-dependent cotranslational protein targeting to membrane
- SRP-dependent cotranslational protein targeting to membrane
- Viral mRNA Translation
- Selenocysteine synthesis
- Major pathway of rRNA processing in the nucleolus and cytosol
- Translation initiation complex formation
- Formation of a pool of free 40S subunits
- Formation of the ternary complex, and subsequently, the 43S complex
- Ribosomal scanning and start codon recognition
- GTP hydrolysis and joining of the 60S ribosomal subunit
- Eukaryotic Translation Termination
- Regulation of expression of SLITs and ROBOs
- Response of EIF2AK4 (GCN2) to amino acid deficiency
- SARS-CoV-1 modulates host translation machinery
- SARS-CoV-2 modulates host translation machinery
- Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
- Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
- PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA
- ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA
|
|
|
Novel |
RPS3A |
ribosomal protein S3A |
- L13a-mediated translational silencing of Ceruloplasmin expression
- Peptide chain elongation
- SRP-dependent cotranslational protein targeting to membrane
- SRP-dependent cotranslational protein targeting to membrane
- Viral mRNA Translation
- Selenocysteine synthesis
- Major pathway of rRNA processing in the nucleolus and cytosol
- Translation initiation complex formation
- Formation of a pool of free 40S subunits
- Formation of the ternary complex, and subsequently, the 43S complex
- Ribosomal scanning and start codon recognition
- GTP hydrolysis and joining of the 60S ribosomal subunit
- Eukaryotic Translation Termination
- Regulation of expression of SLITs and ROBOs
- Response of EIF2AK4 (GCN2) to amino acid deficiency
- SARS-CoV-1 modulates host translation machinery
- SARS-CoV-2 modulates host translation machinery
- Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
- Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
- PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA
- ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA
|
|
|
Novel |
RUNX1T1 |
RUNX1 partner transcriptional co-repressor 1 |
|
|
- Acute myeloid leukemia (AML)
|
Novel |
SERPINA1 |
serpin family A member 1 |
- Platelet degranulation
- COPII-mediated vesicle transport
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Cargo concentration in the ER
- Neutrophil degranulation
- Post-translational protein phosphorylation
|
- Zinc
- 2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol
- Mercaptoethanol
- Recombinant alpha 1-antitrypsin
- PPL-100
- Copper
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
- Alpha-1-antitrypsin (A1AT) deficiency
|
Novel |
SERPINA3 |
serpin family A member 3 |
- Platelet degranulation
- Neutrophil degranulation
|
- Zinc
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
Novel |
SERPINB5 |
serpin family B member 5 |
|
- S,S-(2-Hydroxyethyl)Thiocysteine
|
|
Novel |
SERPINC1 |
serpin family C member 1 |
- Intrinsic Pathway of Fibrin Clot Formation
- Common Pathway of Fibrin Clot Formation
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
- Ardeparin
- Fondaparinux
- Heparin
- Enoxaparin
- N-Formylmethionine
- SR-123781A
- Sulodexide
- Danaparoid
- Dalteparin
- Tinzaparin
- Nadroparin
- Copper
- Protamine sulfate
- Bemiparin
- Antithrombin III human
|
|
Novel |
SERPING1 |
serpin family G member 1 |
- Platelet degranulation
- Intrinsic Pathway of Fibrin Clot Formation
- Defective SERPING1 causes hereditary angioedema
- Regulation of Complement cascade
|
|
- Complement regulatory protein defects, including the following six diseases: C1 inhibitor deficiency (hereditary angioedema); C4 binding protein alpha deficiency; C4 binding protein beta deficiency; Factor I deficiency; Decay-accelerating factor (CD55) deficiency; CD59 deficiency
- Hereditary angioedema
|
Novel |
SGTA |
small glutamine rich tetratricopeptide repeat co-chaperone alpha |
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
|
|
|